Expert Ratings For OptimizeRx
Expert Ratings For OptimizeRx
OptimizerX 的专家评级
OptimizeRx (NASDAQ:OPRX) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
在过去的三个月中，有5位分析师对OptimizerX（纳斯达克股票代码：OPRX）进行了分析，揭示了从看涨到看跌的不同观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $14.6, with a high estimate of $17.00 and a low estimate of $13.00. This current average has increased by 12.31% from the previous average price target of $13.00.
分析师对12个月目标股价的评估提供了更多见解，显示平均目标为14.6美元，最高估计为17.00美元，低估值为13.00美元。目前的平均价格较之前的平均目标价13.00美元上涨了12.31％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析师评级：详细审查
The analysis of recent analyst actions sheds...
对分析师近期行...
登录免费看全文
登录/注册